Reply to Davison, G. Comment on “Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect ® /ColdZyme ® ) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066”

Suzy Huijghebaert, Guido Vanham, Myriam Van Winckel and Karel Allegaert ()
Additional contact information
Suzy Huijghebaert: Independent Researcher, 1310 La Hulpe, Belgium
Guido Vanham: Department of Virology, Institute of Tropical Medicine, Nationale Straat 155, 2000 Antwerp, Belgium
Myriam Van Winckel: Department of Paediatrics, Ghent University Hospital and Ghent University, Corneel Heymanslaan 10, 9000 Ghent, Belgium
Karel Allegaert: Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium

IJERPH, 2022, vol. 20, issue 1, 1-4

Abstract: We have read the comment from Davison with great interest [...]

Keywords: n/a (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/1/631/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/1/631/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2022:i:1:p:631-:d:1019767

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().